Gene expression analysis in sections and tissue microarrays of archival tissues by mRNA in situ hybridization

Histology and Histopathology

Volumn 20, Issue 1, 2005, Pages 225-237

  Henke, R T ^a   Maitra, A ^b   Paik, S ^c   Wellstein, Anton ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NSABP Foundation Inc   (United States)

Author keywords

Expression analysis; In situ hybridization; mRNA; Tissue microarray

Indexed keywords

MESSENGER RNA;

GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABORATORY TEST; NONHUMAN; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL NOISE RATIO; TISSUE MICROARRAY; VALIDATION PROCESS;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 11144274554     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Bismar T.A., Bianco F.J., Zhang H., Li X., Sarkar F.H., Sakr W.A., Grignon D.J. and Che M. (2003). Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections. Pathology 35, 513-517.
2. Bubendorf L., Nocito A., Moch H. and Sauter G. (2001). Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J. Pathol. 195, 72-79.
3. Camp R.L., Charette L.A. and Rimm D.L. (2000). Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80, 1943-1949.
4. Chiesa-Vottero, A.G., Rybicki L.A. and Prayson R.A. (2003). Comparison of proliferation indices in glioblastoma multiforme by whole tissue section vs tissue microarray. Am. J. Clin. Pathol. 120, 902-908.
5. Duyster J., Bai R.Y. and Morris S.W. (2001). Translocations involving anaplastic lymphoma kinase (ALK). Oncogene 20, 5623-5637.
6. Fend F. and Raffeld M. (2000). Laser capture microdissection in pathology. J. Clin. Pathol. 53, 666-672.
7. Fink L., Seeger W., Ermert L. Hanze J., Stahl U., Grimminger F., Kummer W. and Bohle R.M. (1998). Real-time quantitative RT-PCR after laser-assisted cell picking. Nat. Med. 4, 1329-1333.
8. Henke R.T., Bassem H.R., Kim S.E., Rone S.D., Mani A., Jessup J.M., Wellstein A., Maitra A and Riegel A.T. (2004). Overexpression of the nuclear receptor coactivator AIB1 (src-3) during progression of pancreatic adenocarcinoma. Clin. Cancer Res. 10, 6134-6142.
9. Jin L., Thompson C.A., Qian X., Kuecker S.J., Kulig E. and Lloyd R.V. (1999). Analysis of anterior pituitary hormone mRNA expression in immunophenotypically characterized single cells after laser capture microdissection. Lab. Invest. 79, 511-512.
10. Kabbarah O., Pinto K., Mutch D.G. and Goodfellow P.J. (2003). Expression profiling of mouse endometrial cancers microdissected from ethanol-fixed, paraffin-embedded tissues. Am. J. Pathol. 162, 755-762.
11. Kagan B.L., Henke R.T., Cabal-Manzano R., Stoica G.E., Nguyen Q., Wellstein A. and Riegel A.T. (2003). Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Cancer Res. 63, 1696-1705.
12. Klomp H.J., Zernial O., Flachmann S., Wellstein A. and Juhl H. (2002). Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clin. Cancer Res. 8, 823-827.
13. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., Torhorst J., Mihatsch M.J., Sauter G. and Kallioniemi O.P. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844-847.
14. Kurtz A., Wang H.L., Darwiche N., Harris V. and Wellstein A. (1997). Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene 14, 2671-2681.
15. List H.J., Reiter R., Singh B., Wellstein A. and Riegel A.T. (2001). Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res. Treat. 68, 21-28.
16. Liu X.H., Aigner A., Wellstein A., and Ray P.E. (2001). Up-regulation of a fibroblast growth factor binding protein in children with renal diseases. Kidney Int. 59, 1717-1728.
17. Mashour G.A., Wang H.L., Cabal-Manzano R., Wellstein A., Martuza R.L. and Kurtz A. (1999). Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1. J. Invest. Dermatol. 113, 398-402.
18. Mobasheri A., Airley R., Foster C.S., Schulze-Tanzil G. and Shakibaei M. (2004). Post-genomic applications of tissue microarrays: basic research, prognostic oncology, clinical genomics and drug discovery. Histol. Histopathol. 19, 325-335.
19. Moch H., Schraml, P., Bubendorf L., Mirlacher M., Kononen J., Gasser T., Mihatsch M.J., Kallioniemi O.P. and Sauter G. (1999). High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am. J. Pathol. 154, 981-986.
20. Nocito A., Bubendorf L., Maria Tinner E., Suess K., Wagner U., Forster T., Kononen J., Fijan A., Bruderer J. and Schmid U. (2001). Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J. Pathol. 194, 349-357.
21. Paik S. (2003). Clinical trial methods to discover and validate predictive markers for treatment response in cancer. Biotechnol. Annu. Rev. 9, 259-267.
22. Panoskaltsis-Mortari A. and Bucy R.P. (1995). In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. Biotechniques 18, 300-307.
23. Powers C., Aigner A., Stoica G.E., McDonnell K. and Wellstein A. (2002). Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J. Biol. Chem. 277, 14153-14158.
24. Ray R., Cabal-Manzano, R., Moser A.R., Waldman T., Zipper L.M., Aigner A., Byers S.W., Riegel A.T. and Wellstein A. (2003). Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesis. Cancer Res. 63, 8085-8089.
25. Rubin M.A., Dunn R., Strawderman M. and Pienta K.J. (2002). Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am. J. Surg. Pathol. 26, 312-319.
26. Schulte A.M., Malerczyk C., Cabal-Manzano R., Gajarsa J.J., List H.J., Riegel A.T. and Wellstein A. (2000). Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding site. Oncogene 19, 3988-3998.
27. Simon R., Mirlacher M. and Sauter G. (2004). Tissue microarrays. Biotechniques 36, 98-105.
28. Simon R., Nocito A., Hubscher T., Buche C., Torhorst J., Schraml P., Bubendorf L., Mihatsch M.M., Moch H. and Wilber K. (2001). Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J. Natl. Cancer. Inst. 93, 1141-1146.
29. Steel J.H., Harnid Q., Van Noorden S., Jones P., Denny P., Burrin J., Legon S., Bloom S.R. and Polak J.M. (1988). Combined use of in situ hybridisation and immunocytochemistry for the investigation of prolactin gene expression in immature, pubertal, pregnant, lactating and ovariectomised rats. Histochemistry 89, 75-80.
30. Steel J.H., Jeffery R.E., Longcroft J.M., Rogers L.A. and Poulsom R. (1998). Comparison of isotopic and non-isotopic labelling for in situ hybridisation of various mRNA targets with cRNA probes. Eur. J. Histochem. 42, 143-150.
31. Steel J.H., Morgan, D.E., and Poulsom, R. (2001). Advantages of in situ hybridisation over direct or indirect in situ reverse transcriptase-polymerase chain reaction for localisation of galanin mRNA expression in rat small intestine and pituitary. Histochem J. 33, 201-211.
32. Van Deerlin V.M., Gill L.H. and Nelson P.T. (2002). Optimizing gene expression analysis in archival brain tissue. Neurochem, Res. 27, 993-1003.